OSUR insider trading

NasdaqGS Healthcare

ORASURE TECHNOLOGIES INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
578
Last 90 days
25
Buys / sells
5% / 9%
Market cap
$203.10M

About ORASURE TECHNOLOGIES INC

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. The company also provides genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of urine samples; and HEMAcollect protein blood collection device. In addition, it provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, it develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. It sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, and companion animal, markets. The company was founded in 1987 and is headquartered in Bethlehem, Pennsylvania.

Company website: www.orasure.com

OSUR insider activity at a glance

FilingIQ has scored 578 insider transactions for OSUR since Jan 20, 2015. The most recent filing in our index is dated May 14, 2026.

Across the full history, 28 open-market purchases and 52 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on OSUR insider trades is 56.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

13F funds holding OSUR

Frequently asked

How many insider trades does FilingIQ track for OSUR?
FilingIQ tracks 578 Form 4 insider transactions for OSUR (ORASURE TECHNOLOGIES INC), covering filings from Jan 20, 2015 onwards. 25 of those were filed in the last 90 days.
Are OSUR insiders net buyers or net sellers?
Across the full Form 4 history for OSUR, 28 transactions (5%) were open-market purchases and 52 (9%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does OSUR insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is OSUR in?
ORASURE TECHNOLOGIES INC (OSUR) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $203.10M.

Methodology & sources

Every OSUR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.